{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:51:52Z","timestamp":1747381912319},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00106-024-01460-9","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T10:01:43Z","timestamp":1712743303000},"page":"494-498","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stellenwert von ASS-Provokationen beim Analgetika-Intoleranz-Syndrom","Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease"],"prefix":"10.1007","volume":"72","author":[{"given":"Ulrike","family":"F\u00f6rster-Ruhrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Olze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"issue":"5","key":"1460_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/02770908709070955","volume":"24","author":"F Widal","year":"1987","unstructured":"Widal\u00a0F, Abrami\u00a0P, Lermoyez\u00a0J (1987) First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)\u20141922 (with a\u00a0note on aspirin desensitization). By F.\u00a0Widal, P.\u00a0Abrami, J.\u00a0Lermoyez. J\u00a0Asthma 24(5):297\u2013300","journal-title":"J Asthma"},{"issue":"5","key":"1460_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2500\/108854190778879918","volume":"11","author":"Hirschberg","year":"1990","unstructured":"Hirschberg (1990) Anaphylactoid reaction to aspirin (1902). Allergy Proc 11(5):249\u2013250","journal-title":"Allergy Proc"},{"issue":"1","key":"1460_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/all.13599","volume":"74","author":"ML Kowalski","year":"2019","unstructured":"Kowalski\u00a0ML et\u00a0al (2019) Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy 74(1):28\u201339","journal-title":"Allergy"},{"issue":"3","key":"1460_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","volume":"135","author":"JP Rajan","year":"2015","unstructured":"Rajan\u00a0JP et\u00a0al (2015) Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a\u00a0meta-analysis of the literature. J\u00a0Allergy Clin Immunol 135(3):676\u201381 e1","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1460_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik\u00a0A, Nizankowska\u00a0E, Duplaga\u00a0M (2000) Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir\u00a0J 16(3):432\u2013436","journal-title":"Eur Respir J"},{"issue":"5","key":"1460_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1399-3038.2012.01288.x","volume":"23","author":"H Olze","year":"2012","unstructured":"Olze\u00a0H, Lau\u00a0S, Forster\u00a0U (2012) Samter\u2019s triad and eicosanoid imbalance in children with recurrent nasal polyps. Pediatr Allergy Immunol 23(5):500","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"1460_CR7","first-page":"145","volume":"44","author":"H Olze","year":"2006","unstructured":"Olze\u00a0H et\u00a0al (2006) Eosinophilic nasal polyps are a\u00a0rich source of eotaxin, eotaxin\u20112 and eotaxin\u20113. Rhinology 44(2):145\u2013150","journal-title":"Rhinology"},{"issue":"6","key":"1460_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","volume":"192","author":"WW Stevens","year":"2015","unstructured":"Stevens\u00a0WW et\u00a0al (2015) Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease. Am J Respir Crit Care Med 192(6):682\u2013694","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1460_CR9","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","volume":"195","author":"T Liu","year":"2015","unstructured":"Liu\u00a0T et\u00a0al (2015) Aspirin-exacerbated respiratory disease Involves a\u00a0Cysteinyl Leukotriene-driven IL-33-mediated mast cell activation pathway. J\u00a0Immunol 195(8):3537\u20133545","journal-title":"J Immunol"},{"issue":"7","key":"1460_CR10","first-page":"506","volume":"51","author":"T Mewes","year":"1996","unstructured":"Mewes\u00a0T, Riechelmann\u00a0H, Klimek\u00a0L (1996) Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance. Allergy 51(7):506\u2013510","journal-title":"Allergy"},{"issue":"5949","key":"1460_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","volume":"1","author":"A Szczeklik","year":"1975","unstructured":"Szczeklik\u00a0A, Gryglewski\u00a0RJ, Czerniawska-Mysik\u00a0G (1975) Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med\u00a0J 1(5949):67\u201369","journal-title":"Br Med J"},{"issue":"2","key":"1460_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4193\/Rhin20.601","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens\u00a0WJ et\u00a0al (2020) Executive summary of EPOS 2020 including integrated care pathways. Rhinology 58(2):82\u2013111","journal-title":"Rhinology"},{"issue":"5","key":"1460_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","volume":"116","author":"K Mascia","year":"2005","unstructured":"Mascia\u00a0K et\u00a0al (2005) Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J\u00a0Allergy Clin Immunol 116(5):970\u2013975","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1460_CR14","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","volume":"61","author":"T Van Zele","year":"2006","unstructured":"Van Zele\u00a0T et\u00a0al (2006) Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61(11):1280\u20131289","journal-title":"Allergy"},{"issue":"40","key":"1460_CR15","doi-asserted-by":"publisher","first-page":"e27471","DOI":"10.1097\/MD.0000000000027471","volume":"100","author":"M Bertlich","year":"2021","unstructured":"Bertlich\u00a0M et\u00a0al (2021) Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab. Medicine 100(40):e27471","journal-title":"Medicine"},{"issue":"6","key":"1460_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11882-014-0441-9","volume":"14","author":"L Klimek","year":"2014","unstructured":"Klimek\u00a0L et\u00a0al (2014) Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Curr Allergy Asthma Rep 14(6):441","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"1460_CR17","first-page":"226","volume":"58","author":"U Forster-Ruhrmann","year":"2020","unstructured":"Forster-Ruhrmann\u00a0U et\u00a0al (2020) Omalizumab in patients with NSAIDs-exacerbated respiratory disease. Rhinology 58(3):226\u2013232","journal-title":"Rhinology"},{"issue":"7","key":"1460_CR18","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","volume":"7","author":"TM Laidlaw","year":"2019","unstructured":"Laidlaw\u00a0TM et\u00a0al (2019) Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J\u00a0Allergy Clin Immunol Pract 7(7):2462\u20132465 e1","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5414\/ALX02422E","volume":"7","author":"K Brockow","year":"2023","unstructured":"Brockow\u00a0K et\u00a0al (2023) Guideline for allergological diagnosis of drug hypersensitivity reactions: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in cooperation with the German Dermatological Society (DDG), the Association of German Allergologists (ADA), the German Society for Pediatric Allergology (GPA), the German Contact Dermatitis Research Group (DKG), the German Society for Pneumology (DGP), the German Society of Otorhinolaryngology, Head and Neck Surgery, the Austrian Society of Allergology and Immunology (OGAI), the Austrian Society of Dermatology and Venereology (OGDV), the German Academy of Allergology and Environmental Medicine (DAAU), and the German Documentation Center for Severe Skin Reactions (dZh). Allergol Select 7:122\u2013139","journal-title":"Allergol Select"},{"issue":"10","key":"1460_CR20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","volume":"62","author":"E Nizankowska-Mogilnicka","year":"2007","unstructured":"Nizankowska-Mogilnicka\u00a0E et\u00a0al (2007) EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62(10):1111\u20131118","journal-title":"Allergy"},{"issue":"5","key":"1460_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/0091-6749(76)90059-2","volume":"57","author":"CR Zeiss","year":"1976","unstructured":"Zeiss\u00a0CR, Lockey\u00a0RF (1976) Refractory period to aspirin in a\u00a0patient with aspirin-induced asthma. J\u00a0Allergy Clin Immunol 57(5):440\u2013448","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1460_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000193780","volume":"34","author":"M Pasargiklian","year":"1977","unstructured":"Pasargiklian\u00a0M et\u00a0al (1977) Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 34(2):78\u201391","journal-title":"Respiration"},{"issue":"1","key":"1460_CR23","first-page":"60","volume":"67","author":"G Patriarca","year":"1991","unstructured":"Patriarca\u00a0G et\u00a0al (1991) Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Ann Allergy 67(1):60\u201362","journal-title":"Ann Allergy"},{"issue":"5","key":"1460_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","volume":"15","author":"E Nizankowska","year":"2000","unstructured":"Nizankowska\u00a0E et\u00a0al (2000) Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir\u00a0J 15(5):863\u2013869","journal-title":"Eur Respir J"},{"issue":"5","key":"1460_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","volume":"101","author":"M Milewski","year":"1998","unstructured":"Milewski\u00a0M et\u00a0al (1998) Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J\u00a0Allergy Clin Immunol 101(5):581\u2013586","journal-title":"J Allergy Clin Immunol"},{"key":"1460_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5414\/ALX01996E","volume":"4","author":"U Forster-Ruhrmann","year":"2020","unstructured":"Forster-Ruhrmann\u00a0U et\u00a0al (2020) Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)? Allergol Sel 4:135\u2013143","journal-title":"Allergol Sel"},{"issue":"8","key":"1460_CR27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00106-019-0668-9","volume":"67","author":"U Forster-Ruhrmann","year":"2019","unstructured":"Forster-Ruhrmann\u00a0U et\u00a0al (2019) Nasal provocation with increased ASA dose: improved \u201enon-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease\u201c (N-ERD) detection rate in chronic rhinosinusitis patients. HNO 67(8):620\u2013627","journal-title":"HNO"},{"issue":"3","key":"1460_CR28","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.2500\/ajra.2012.26.3767","volume":"26","author":"S Vaidyanathan","year":"2012","unstructured":"Vaidyanathan\u00a0S, Williamson\u00a0PA, Lipworth\u00a0BJ (2012) Is a\u00a0positive nasal lysine-aspirin challenge test associated with a\u00a0more severe phenotype of chronic rhinosinusitis and asthma? am j rhinol allergy 26(3):e89\u201393","journal-title":"am j rhinol allergy"},{"issue":"3","key":"1460_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaip.2015.01.012","volume":"3","author":"KC Bergmann","year":"2015","unstructured":"Bergmann\u00a0KC, Zuberbier\u00a0T, Church\u00a0MK (2015) Omalizumab in the treatment of aspirin-exacerbated respiratory disease. J\u00a0Allergy Clin Immunol Pract 3(3):459\u2013460","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-024-01460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-024-01460-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-024-01460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T12:02:33Z","timestamp":1718971353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-024-01460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s00106-024-01460-9","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"2 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0F\u00f6rster-Ruhrmann und H.\u00a0Olze geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}